tirzepatide po FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Addressing the Weight Loss Injectable
Description
Compounded medications are not individually FDA-approved products, though they use FDA-approved active ingredients
Previously, 2.4mg Semaglutide injection lost 15.8% of weight at 68 weeks (STEP-8 trial)
If body composition is shifting (muscle gained, fat lost), weight may plateau while your actual progress continues
Four weeks provides sufficient time for several critical adaptations
Its unlikely to become available to patients until 2027 at the soonest
Intravenous fluid replacement may be needed
